Using blood and cervical tests to track cervical cancer treatment response
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have cervical cancer linked to HPV (squamous cell, adenocarcinoma, or adenosquamous type)
- Your cancer is stage I or higher, or has spread to other parts of the body
- You have a tumor that can be seen on imaging scans, and you will have follow-up scans after treatment
- You agree to give blood samples and cervical mucus samples for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
This trial uses a special blood test to look for tumor DNA in your blood to monitor for cervical cancer recurrence and help guide treatment decisions. It may help your doctor know if your cancer is coming back and choose the best treatment options.
This study looks at whether simple blood tests can help predict how well first-line treatment works for cervical cancer that has come back or spread. It aims to improve future care by tracking changes in the blood over time.
This study tests whether patients with a specific type of HPV-positive throat cancer can safely skip radiation after surgery by using blood tests to monitor for cancer recurrence. The goal is to reduce side effects while keeping patients cancer-free.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.